Skip to content

Supplier News

CRN comments on FDA NDI guidance

CRN comments on FDA NDI guidance

In regard to FDA issuing draft guidance on NDI notification master files for supplements today, CRN president and CEO Steve Mister offered the following comments on the development: “It’s a positive development to see the FDA moving ahead with this draft guidance.

Upsher-Smith launches methimazole tablets

Upsher-Smith launches methimazole tablets

MAPLE GROVE, Minn. – Upsher-Smith Laboratories announced the recent launch of methimazole tablets, USP, 5 mg and 10 mg. The methimazole tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according to IQVIA.

LexisNexis Risk Solutions releases new fraud study

LexisNexis Risk Solutions releases new fraud study

LexisNexis Risk Solutions has revealed the findings of the fourteenth edition of its annual LexisNexis True Cost of Fraud Study: Ecommerce and Retail Report – U.S. and Canada Edition. The report, based on a commissioned survey conducted by Forrester Consulting, shows that merchants in the U.S.